G3BP1 modulates SPOP to promote prostate tumorigenesis
Related Experiment Video
Updated: Oct 1, 2025

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
Published on: June 13, 2019
Chandrani Mukhopadhyay1, Pengbo Zhou1
1Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA.
Abstract:
Speckle-type POZ protein (SPOP), a Cullin 3-based ubiquitin ligase (CUL3SPOP), acts as a prostate-specific tumor suppressor. Loss-of-function mutations in SPOP occur in 10% of primary prostate cancer with a high Gleason grade and poor prognosis. However, it is unclear how the ubiquitin ligase activity of SPOP is controlled and how dysregulation of SPOP contributes to malignant transformation. Here, we identified GTPase Activating Protein (SH3 Domain) Binding Protein 1 (G3BP1) as an interactor and upstream regulator of CUL3SPOP, and it functions as an inhibitor of CUL3SPOP ubiquitin ligase, suggesting a distinctive mode of CUL3SPOP inactivation that aggravates prostate cancer.
Insights
Speckle-type POZ protein (SPOP) is a prostate tumor suppressor. Researchers found G3BP1 inhibits SPOP
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Speckle-type POZ protein (SPOP) functions as a prostate-specific tumor suppressor.
- Loss-of-function SPOP mutations are linked to aggressive prostate cancer with poor prognosis.
- Mechanisms controlling SPOP's ubiquitin ligase activity and its role in cancer progression remain unclear.
Purpose of the Study:
- To investigate the upstream regulators of the CUL3SPOP ubiquitin ligase complex.
- To elucidate the functional relationship between SPOP and its interactors in prostate cancer.
Main Methods:
- Protein-protein interaction studies to identify SPOP interactors.
- Biochemical assays to determine the regulatory role of identified interactors on CUL3SPOP activity.
- Analysis of SPOP mutations in prostate cancer datasets.
Main Results:
- GTPase Activating Protein (SH3 Domain) Binding Protein 1 (G3BP1) was identified as a novel interactor of CUL3SPOP.
- G3BP1 acts as an upstream inhibitor of CUL3SPOP ubiquitin ligase activity.
- This inhibitory interaction suggests a novel mechanism for CUL3SPOP inactivation.
Conclusions:
- G3BP1 is a key regulator of CUL3SPOP, functioning as an inhibitor.
- Dysregulation of the G3BP1-CUL3SPOP interaction may contribute to prostate cancer progression.
- This finding reveals a new pathway for CUL3SPOP inactivation in prostate tumorigenesis.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
GTPases and their Regulation
Large G-proteins,...
Gene Regulation During Sporulation
The Ras Gene
Ras is a...
TGF - β Signaling Pathway

